AGL 38.34 Increased By ▲ 0.32 (0.84%)
AIRLINK 214.00 Increased By ▲ 16.64 (8.43%)
BOP 9.86 Increased By ▲ 0.32 (3.35%)
CNERGY 6.50 Increased By ▲ 0.59 (9.98%)
DCL 9.16 Increased By ▲ 0.34 (3.85%)
DFML 38.20 Increased By ▲ 2.46 (6.88%)
DGKC 100.50 Increased By ▲ 3.64 (3.76%)
FCCL 36.06 Increased By ▲ 0.81 (2.3%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 14.49 Increased By ▲ 1.32 (10.02%)
HUBC 134.20 Increased By ▲ 6.65 (5.21%)
HUMNL 13.69 Increased By ▲ 0.19 (1.41%)
KEL 5.63 Increased By ▲ 0.31 (5.83%)
KOSM 7.21 Increased By ▲ 0.21 (3%)
MLCF 45.25 Increased By ▲ 0.55 (1.23%)
NBP 61.60 Increased By ▲ 0.18 (0.29%)
OGDC 232.78 Increased By ▲ 18.11 (8.44%)
PAEL 40.97 Increased By ▲ 2.18 (5.62%)
PIBTL 8.54 Increased By ▲ 0.29 (3.52%)
PPL 203.10 Increased By ▲ 10.02 (5.19%)
PRL 40.00 Increased By ▲ 1.34 (3.47%)
PTC 28.25 Increased By ▲ 2.45 (9.5%)
SEARL 107.70 Increased By ▲ 4.10 (3.96%)
TELE 8.74 Increased By ▲ 0.44 (5.3%)
TOMCL 36.25 Increased By ▲ 1.25 (3.57%)
TPLP 13.90 Increased By ▲ 0.60 (4.51%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 34.70 Increased By ▲ 1.73 (5.25%)
WTL 1.71 Increased By ▲ 0.11 (6.88%)
BR100 12,240 Increased By 513.2 (4.38%)
BR30 38,279 Increased By 1902.2 (5.23%)
KSE100 113,961 Increased By 4448.3 (4.06%)
KSE30 36,066 Increased By 1552.4 (4.5%)
Technology

Oxford student invents artificial retina

An Oxford University student recently created a soft, synthetic tissue retina that could be useful for visually impa
Published May 6, 2017

An Oxford University student recently created a soft, synthetic tissue retina that could be useful for visually impaired people.

Vanessa Restrepo-Schild, a 24-year-old Dphil student, who performed the research, was the first one to productively use biological, synthetic tissues that were created in a laboratory environment.

This research will be able to modernize the bionic implant industry along with progress of new and less invasive technologies that are similar to human body tissues which will in turn help to cure degenerative eye condition like retinitis pigmentosa, reported Science Daily.

Vanessa, the team leader, generated the double layered synthetic retina which imitates the normal human retinal process. The new discovery includes soft water droplets, known as hydrogels, and few biological cell membrane proteins. The cells’ function is to sense and respond to light in order to form a grey scale image, informed their study published in Scientific Reports.

“The synthetic material can generate electrical signals, which stimulate the neurons at the back of our eye just like the original retina,” described Vanessa.

The cells are made from natural and biodegradable resources that do not contain foreign bodies or any kind of living entities, contrasting from the already existing artificial retinal implants. This technique makes the new implant less invasive as compared to a mechanical devise and also is less probable to contain a bad reaction on the body. “The human eye is incredibly sensitive, which is why foreign bodies like metal retinal implants can be so damaging, leading to inflammation and/or scaring. But a biological synthetic implant is soft and water based, so much more friendly to the eye environment.”

Vanessa continued, “I have taken the principals behind vital bodily functions, e.g. our sense of hearing, touch and the ability to detect light, and replicated them in a laboratory environment with natural, synthetic components. I hope my research is the first step in a journey towards building technology that is soft and biodegradable instead of hard and wasteful.”

Though being tested in laboratory conditions only, Vanessa is looking forward to build on her first work and to look at possible uses with living tissues. This could prove to be important in signifying the performance of the material as a bionic implant.

Daily Mail informed that Vanessa has already filed a patent for this technology and the next step of this will include the team to expand the replica’s function in order to distinguish various colors.

The team desires to carry out animal tests for retina which will later be followed by human clinical trials.

Copyright Business Recorder, 2017

Comments

Comments are closed.